Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease - PubMed
- ️Sat Jan 01 1994
Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease
A C Alonso et al. Proc Natl Acad Sci U S A. 1994.
Abstract
The microtubule assembly-promoting activity of different pools of tau protein isolated from Alzheimer disease (AD) and control brains and the effect of dephosphorylation on this activity were studied. Tau isolated from a 2.5% perchloric extract of AD brain had almost the same activity as that obtained from control brain, and this activity did not change significantly on dephosphorylation. Abnormally phosphorylated tau (AD P-tau) isolated from brain homogenate of AD patients had little activity, and upon dephosphorylation with alkaline phosphatase, its activity increased to approximately the same level as the acid-soluble tau. Addition of AD P-tau to a mixture of normal tau and tubulin inhibited microtubule assembly. AD P-tau bound to normal tau but not to tubulin. These studies suggest that the abnormal phosphorylation of tau might be responsible for the breakdown of microtubules in affected neurons in AD not only because the altered protein has little microtubule-promoting activity but also because it interacts with normal tau, making the latter unavailable for promoting the assembly of tubulin into microtubules.
Similar articles
-
Alzheimer paired helical filaments. Restoration of the biological activity by dephosphorylation.
Iqbal K, Zaidi T, Bancher C, Grundke-Iqbal I. Iqbal K, et al. FEBS Lett. 1994 Jul 25;349(1):104-8. doi: 10.1016/0014-5793(94)00650-4. FEBS Lett. 1994. PMID: 8045285
-
Wang JZ, Grundke-Iqbal I, Iqbal K. Wang JZ, et al. Brain Res Mol Brain Res. 1996 Jun;38(2):200-8. doi: 10.1016/0169-328x(95)00316-k. Brain Res Mol Brain Res. 1996. PMID: 8793108
-
Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
Wang JZ, Grundke-Iqbal I, Iqbal K. Wang JZ, et al. Eur J Neurosci. 2007 Jan;25(1):59-68. doi: 10.1111/j.1460-9568.2006.05226.x. Eur J Neurosci. 2007. PMID: 17241267 Free PMC article.
-
Molecular pathology of Alzheimer neurofibrillary degeneration.
Iqbal K, Alonso A, Gong C, Khatoon S, Kudo T, Singh T, Grundke-Iqbal I. Iqbal K, et al. Acta Neurobiol Exp (Wars). 1993;53(1):325-35. Acta Neurobiol Exp (Wars). 1993. PMID: 8317268 Review.
-
Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach.
Iqbal K, Alonso AD, Gondal JA, Gong CX, Haque N, Khatoon S, Sengupta A, Wang JZ, Grundke-Iqbal I. Iqbal K, et al. J Neural Transm Suppl. 2000;59:213-22. doi: 10.1007/978-3-7091-6781-6_22. J Neural Transm Suppl. 2000. PMID: 10961432 Review.
Cited by
-
Human tau expression reduces adult neurogenesis in a mouse model of tauopathy.
Komuro Y, Xu G, Bhaskar K, Lamb BT. Komuro Y, et al. Neurobiol Aging. 2015 Jun;36(6):2034-42. doi: 10.1016/j.neurobiolaging.2015.03.002. Epub 2015 Mar 9. Neurobiol Aging. 2015. PMID: 25863528 Free PMC article.
-
Slater C, Wang Q. Slater C, et al. Clin Transl Med. 2021 Apr;11(4):e397. doi: 10.1002/ctm2.397. Clin Transl Med. 2021. PMID: 33931975 Free PMC article. Review.
-
Truncation of Tau selectively facilitates its pathological activities.
Gu J, Xu W, Jin N, Li L, Zhou Y, Chu D, Gong CX, Iqbal K, Liu F. Gu J, et al. J Biol Chem. 2020 Oct 2;295(40):13812-13828. doi: 10.1074/jbc.RA120.012587. Epub 2020 Jul 31. J Biol Chem. 2020. PMID: 32737201 Free PMC article.
-
Jaberi S, Fahnestock M. Jaberi S, et al. Biomolecules. 2023 Oct 26;13(11):1577. doi: 10.3390/biom13111577. Biomolecules. 2023. PMID: 38002258 Free PMC article. Review.
-
Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration.
Pérez MJ, Jara C, Quintanilla RA. Pérez MJ, et al. Front Neurosci. 2018 Jul 5;12:441. doi: 10.3389/fnins.2018.00441. eCollection 2018. Front Neurosci. 2018. PMID: 30026680 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical